Table 1.
Cut-off method, seroprevalence and vaccine exposure in percentages, and number of individuals per antigen.
| Antigen, pathogen | Disease | Percent seroprevalence with 95% CI | n |
|---|---|---|---|
| Gaussian mixture model (2 distributions) | |||
| Bm33, Brugia malayi | Lymphatic Filariasis | 10.9 (10.2, 11.6) | 8129 |
| Wb123, Wucheria Bancrofti | Lymphatic Filariasis | 1.7 (1.5, 2.02) | 8128 |
| NIE, Strongyloides stercoralis | Strongyloidiasis | 16.8 (16.7, 16.9) | 8131 |
| SAG2A, Toxoplasma gondii | Toxoplasmosis | 29.9 (28.9, 30.1) | 7430 |
| Rp17, Treponemal pallidum pertenue | Yaws | 4.9 (3.9, 6.1) | 1529 |
| TmpA, Treponemal pallidum pertenue | Yaws | 4.8 (4.00, 5.8) | 1660 |
| Rp17 TmpA double positive | Yaws | 1.2 (0.7, 1.8) | 1638* |
| VSP3 + VSP5, Giardia duodenalis | Giardiasis | 23.2 (22.3-24.2) | 7682 |
| K-means clustering (k = 3) | |||
| Bm14+BmR1, Brugia malayi | Lymphatic Filariasis | 3.5 (3.1, 4.00) | 6855 |
| Pgp3+Ct694, Chlamydia trachomatis | Trachoma | 4.5 (3.7, 5.5) | 1970 |